{
  "trial_id": "NCT00312637",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "diagnosed with recent invasive breast cancer",
      "label": "met",
      "evidence": "cytologically confirmed breast cancer"
    },
    {
      "criterion": "no previous ipsilateral axillary surgery",
      "label": "met",
      "evidence": "no previous ipsilateral axillary surgery"
    }
  ],
  "exclusion": [
    {
      "criterion": "diagnosed with in situ disease",
      "label": "not_met",
      "evidence": ""
    },
    {
      "criterion": "previous ipsilateral axillary surgery",
      "label": "not_met",
      "evidence": ""
    },
    {
      "criterion": "MRI/MRA contraindications",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "contrast reaction to intravenous gadolinium-DTPA",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "clinically not stable",
      "label": "not_met",
      "evidence": ""
    },
    {
      "criterion": "cannot give consent",
      "label": "not_met",
      "evidence": ""
    }
  ],
  "notes": "45-year-old postmenopausal woman with HER2-positive and ER/PR negative invasive ductal breast carcinoma, metastatic lesions on CXR.",
  "_meta": {
    "topic_id": "61",
    "trial_id": "NCT00312637",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}